Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolase

Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amine compounds are described, which are useful as LTA4 hydrolase (LTA4H) modulators. Such compounds may be used in pharmaceutical compositions and methods for modulation of LTA4H and for the treatment of disease states, disorders, an...

Full description

Saved in:
Bibliographic Details
Main Authors EUGENE Y. CHEUNG, ALVAH T. WICKBOLDT, DIEGO BROGGINI, ANNE M. FOURINE, LAURENT GOMEZ, GENESIS M. BACANI, XIAOHU DENG, HARTMUT ZINSER, CHRISTA C. CHROVIAN, JIMMY T. LIANG, VIRGINIA M. TANIS, AARON M. KEARNEY, KATHLEEN C. SAPPEY, SUSANNE LOCHNER, JOHN, J.M. WIENER, KIA SEPASSI, ALEJANDRO SANTILLAN JR, NEELAKANDHA S. MANI, CHERYL A. GRICE, ADRIENNE M. LANDRY-BAYLE, ALICE LEE-DUTRA
Format Patent
LanguageEnglish
Published 15.10.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amine compounds are described, which are useful as LTA4 hydrolase (LTA4H) modulators. Such compounds may be used in pharmaceutical compositions and methods for modulation of LTA4H and for the treatment of disease states, disorders, and conditions mediated by LTA4 hydrolase activity.
Bibliography:Application Number: AU20090234140